The gut microbiome serves as a signaling hub that integrates environmental inputs with
genetic and immune signals to influence the host's metabolism and immunity. Gut bacteria …

Inflammatory bowel disease (IBD) is a complex multifactorial chronic inflammatory disease,
that includes Crohn's disease (CD) and ulcerative colitis (UC), having progressively …

Anti-tumor necrosis factor (anti-TNF) therapy has been successfully used as first-line
biologic treatment for moderate-to-severe inflammatory bowel disease (IBD), in both “step …

Current inflammatory bowel disease (IBD) treatments including non-biological, biological,
and nutritional therapies aim to achieve remission and mucosal healing. Treatment efficacy …

Loss of response to therapy in inflammatory bowel disease (IBD) has led to a surge in
research focusing on precision medicine. Three systematic reviews have been published …

Inflammatory bowel disease (IBD) is a chronic immune‐mediated intestinal disease
consisting of ulcerative colitis and Crohn's disease. Inflammatory bowel disease is believed …

Background Inflammatory bowel disease (IBD) is a chronic relapsing-remitting disease. An
adverse immune reaction toward the intestinal microbiota is involved in the pathophysiology …

Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are
chronic immune-mediated intestinal inflammatory disorders associated with microbial …

Gut bacterial dysbiosis plays a vital role in the development of Alzheimer's disease (AD).
However, our understanding of alterations to the gut fungal microbiota and their correlations …

Inflammatory bowel diseases (IBD) are chronic disorders of the gastrointestinal tract that
have been linked to microbiome dysbiosis and immune system dysregulation. We …